News

NOV-FEBPS Anti-Cancer Symposium

2015-11-253,625

“NOV-FEBPS Anti-Cancer Symposium – “Personalized Anti-Cancer Therapy & Companion Diagnostics”

When: 2015, 11, 25 (Wed), 1:00 – 5:40 pm

Where: SC Convention Center, Gangnam Center, (Iris Hall 12th Floor),

                Gangnam-Gu, Teheran-Ro, 7-Gil 22,

 

Symposium Program

 

1:00 – 1:30:       Registration

1:30 – 1:40:       Opening Remark & Welcome Address (By Dr. In-Chull Kim, CEO & President, National OncoVentrue)

 Session 1  (Chair: Dr. Shin-Hong Kang, JW pharmaceutical)

1:40 – 2:15:       “Personalized anti-cancer therapy overcoming tumor heterogeity and clonal evolution” (Professor Yeul-Hong Kim, Korea University Hospital)

2:15 – 2:50:       “Companion tests for lung cancer targeted therapies” (Dr. Mao Mao, SVP, Translational Bioscience and Diagnostics at WuXi AppTec)

2:50 – 3:25:       “ddPCR based IVD-CDx for lung or colorectal cancer patient” (Professor Young-Kee Shin, Seoul University)

3:25 – 3:50:       Group Photo & Coffee Break

Session 2  (Chair: Dr. Tae-Young Yoon, Dong-A Socio R&D Center)

3:50 – 4:25:       “Roche’s Experience in Personalized anti-cancer therapy” (Dr. James Creeden, Medical Director, Roche China)

4:25 – 5:00:       “Integration of NGS & PDX technologies for precision oncology” (Professor Jong-il Kim, Seoul University)

5:00 – 5:35:       “Clinical genomics in the Cloud” (Dr. Kwang-Joong Kim, Bioinformatics Business, KT)

5:35 – 5:40:         Closing Remark (By Dr. Young-Whan Park, President, FEBPS)